Mediera Corporation (TPEX:5398)
Taiwan · Delayed Price · Currency is TWD 14.20
+0.25 (1.79%)
Aug 19, 2026, 1:09 PM CST
Mediera Market Cap
Mediera has a market cap or net worth of 702.4 million as of August 19, 2026. Its market cap has decreased by -30.39% in one year.
Market Cap
702.40M
Enterprise Value
528.17M
Revenue
195.89M
Ranking
n/a
PE Ratio
142.81
Stock Price
14.20
ChartMarket Cap Chart
Since November 3, 2004, Mediera's market cap has increased from 257.38M to 702.40M, an increase of 172.90%. That is a compound annual growth rate of 4.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 702.40M | -45.38% |
| Dec 31, 2025 | 1.29B | 33.67% |
| Dec 31, 2024 | 962.10M | 27.54% |
| Dec 29, 2023 | 754.35M | -7.01% |
| Dec 30, 2022 | 811.23M | -19.01% |
| Dec 30, 2021 | 1.00B | 4.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeneFerm Biotechnology | 1.27B |
| InnoPharmax | 1.23B |
| Excelsior Biopharma | 1.13B |
| Prince Pharmaceutical | 1.07B |
| DV Biomed | 1.03B |
| Original BioMedicals | 942.23M |
| Anxo Pharmaceutical | 919.08M |
| Winston Medical Supply | 916.25M |